Skip to main content
Erschienen in: Journal of Gastroenterology 9/2017

26.06.2017 | Review

Clinical practice guideline for post-ERCP pancreatitis

verfasst von: Tetsuya Mine, Toshio Morizane, Yoshiaki Kawaguchi, Ryukichi Akashi, Keiji Hanada, Tetsuhide Ito, Atsushi Kanno, Mitsuhiro Kida, Hiroyuki Miyagawa, Taketo Yamaguchi, Toshihiko Mayumi, Yoshifumi Takeyama, Tooru Shimosegawa

Erschienen in: Journal of Gastroenterology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Endoscopic retrograde cholangiopancreatography (ERPC) is used for the diagnosis and treatment of pancreatic and biliary diseases. Post-ERCP pancreatitis (PEP) is a complication which needs special care and clinical practice guideline for this morbidity is also needed.

Methods

The key clinical issues of diagnosis and treatment of PEP were listed and checked, and then the clinical questions were formulated. PubMed (MEDLINE) and Ichushi-web (Japanese medical literature) were used as databases. For the study of diagnostic test accuracy, items similar to QUADAS-2, i.e., random selection from a population to which the diagnostic test is applied, blinding of index tests and reference tests, completeness of reference standard, completeness of test implementations, the same timing of tests, and missing data were assessed as well as the indirectness of the study subjects, index tests, reference standard, and outcomes. Grading of recommendations was determined as strong or weak. In clinical practice, the judgment of attending doctors should be more important than recommendations described in clinical practice guidelines. Gastroenterologists are the target users of this clinical practice guideline. General practitioners or general citizens are not supposed to use this guideline. The guideline committee has decided to include wide clinical issues such as etiological information, techniques of ERCP, the diagnosis, treatments, and monitoring of PEP in this guideline.

Results

In this concise report, we described ten clinical questions, recommendations, and explanations pertaining to risk factors, diagnosis, prognostic factors, treatments, and preventive interventions in the medical practice for PEP.

Conclusions

We reported here the essence of the clinical practice guideline for PEP.
Literatur
4.
Zurück zum Zitat Minds Guideline Center, Japan Council for Quality Health Care. Minds handbook for clinical practice guideline development 2014. 2014. Minds Guideline Center, Japan Council for Quality Health Care. Minds handbook for clinical practice guideline development 2014. 2014.
5.
Zurück zum Zitat Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2 Group: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.CrossRefPubMed Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2 Group: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.CrossRefPubMed
6.
Zurück zum Zitat Villatoro E, Bassi C, Larvin M. Antibiotics therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2006;4:CD002941. Villatoro E, Bassi C, Larvin M. Antibiotics therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2006;4:CD002941.
7.
Zurück zum Zitat Working UK. Party on acute pancreatitis: UK guidelines for management of acute pancreatitis. Gut. 2005;54(Suppl 3):31–9. Working UK. Party on acute pancreatitis: UK guidelines for management of acute pancreatitis. Gut. 2005;54(Suppl 3):31–9.
8.
Zurück zum Zitat Forsmark CE, Baillie J. AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board, AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022–44.CrossRefPubMed Forsmark CE, Baillie J. AGA Institute Clinical Practice and Economics Committee, AGA Institute Governing Board, AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132:2022–44.CrossRefPubMed
9.
Zurück zum Zitat Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg. 1998;2:496–503.CrossRefPubMed Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg. 1998;2:496–503.CrossRefPubMed
10.
Zurück zum Zitat Sharma VK, Howden CW. Prophylactic antibiotics administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas. 2001;22:28–31.CrossRefPubMed Sharma VK, Howden CW. Prophylactic antibiotics administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas. 2001;22:28–31.CrossRefPubMed
11.
Zurück zum Zitat de Vries AC, Besselink MGH, Buskens E, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology. 2007;7:531–8.CrossRefPubMed de Vries AC, Besselink MGH, Buskens E, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology. 2007;7:531–8.CrossRefPubMed
12.
Zurück zum Zitat Bai Y, Gao J, Zou D, et al. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008;103:104–10.CrossRefPubMed Bai Y, Gao J, Zou D, et al. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008;103:104–10.CrossRefPubMed
13.
Zurück zum Zitat Akshintala VS, Hutfless SM, Colantuoni E, et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38:1325–37.CrossRefPubMed Akshintala VS, Hutfless SM, Colantuoni E, et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38:1325–37.CrossRefPubMed
14.
Zurück zum Zitat Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotics prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176:480–3.PubMed Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotics prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176:480–3.PubMed
15.
Zurück zum Zitat Schwarz M, Isenmann R, Meyer H, et al. Antibiotic use in necrotizing pancreatitis. Results of controlled study. Dtsch Med Wochenschr. 1997;122:356–61.CrossRefPubMed Schwarz M, Isenmann R, Meyer H, et al. Antibiotic use in necrotizing pancreatitis. Results of controlled study. Dtsch Med Wochenschr. 1997;122:356–61.CrossRefPubMed
16.
Zurück zum Zitat Nordback I, Sand J, Saaristo R, et al. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis—a single-center randomized study. J Gastrointest Surg. 2001;5:113–8.CrossRefPubMed Nordback I, Sand J, Saaristo R, et al. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis—a single-center randomized study. J Gastrointest Surg. 2001;5:113–8.CrossRefPubMed
17.
Zurück zum Zitat Manes G, Rabitti PG, Menchise A, et al. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas. 2003;27:e79–83.CrossRefPubMed Manes G, Rabitti PG, Menchise A, et al. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas. 2003;27:e79–83.CrossRefPubMed
18.
Zurück zum Zitat Manes G, Uomo I, Menchise A, et al. Timing of antibiotics prophylaxis in acute pancreatitis: a controlled randomized study with meropenem. Am J Gastroenterol. 2006;101:1348–53.CrossRefPubMed Manes G, Uomo I, Menchise A, et al. Timing of antibiotics prophylaxis in acute pancreatitis: a controlled randomized study with meropenem. Am J Gastroenterol. 2006;101:1348–53.CrossRefPubMed
19.
Zurück zum Zitat Isennman R, Runzi M, Kroon M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126:997–1004.CrossRef Isennman R, Runzi M, Kroon M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126:997–1004.CrossRef
20.
Zurück zum Zitat Grag PK, Khanna S, Bohidar NP, et al. Incidence, spectrum and antibiotic sensitivity pattern of bacterial infections among patients with acute pancreatitis. J Gastroenterol Hepatol. 2001;16:1055–9.CrossRef Grag PK, Khanna S, Bohidar NP, et al. Incidence, spectrum and antibiotic sensitivity pattern of bacterial infections among patients with acute pancreatitis. J Gastroenterol Hepatol. 2001;16:1055–9.CrossRef
21.
Zurück zum Zitat Kadokawa Y, Takeda K, Sunamura M, et al. Effectiveness of continuous arterial infusion of protease inhibitors for experimental acute pancreatitis caused by the creation of a blind duodenal loop. J Jpn Soc Gastroenterol. 1990;87:1444–50. Kadokawa Y, Takeda K, Sunamura M, et al. Effectiveness of continuous arterial infusion of protease inhibitors for experimental acute pancreatitis caused by the creation of a blind duodenal loop. J Jpn Soc Gastroenterol. 1990;87:1444–50.
22.
Zurück zum Zitat Hayashi J, Kawarada Y, Isaji S, et al. Therapeutic effects of continuous itraarterial antibiotics infusion in preventing pancreatic infection in experimental acute necrotizing pancreatitis. Pancreas. 1996;13:184–92.CrossRefPubMed Hayashi J, Kawarada Y, Isaji S, et al. Therapeutic effects of continuous itraarterial antibiotics infusion in preventing pancreatic infection in experimental acute necrotizing pancreatitis. Pancreas. 1996;13:184–92.CrossRefPubMed
23.
Zurück zum Zitat Mikami Y, Takeda K, Matsuda K, et al. Rat experimental model of regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas. 2005;30:248–53.CrossRefPubMed Mikami Y, Takeda K, Matsuda K, et al. Rat experimental model of regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis. Pancreas. 2005;30:248–53.CrossRefPubMed
24.
Zurück zum Zitat Takeda K, Matsuno S, Sunamura M, et al. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg. 1996;171:394–8 (level 3b).CrossRefPubMed Takeda K, Matsuno S, Sunamura M, et al. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis. Am J Surg. 1996;171:394–8 (level 3b).CrossRefPubMed
25.
Zurück zum Zitat Takeda K, Yamauchi J, Shibuya K, et al. Benefit of continuous regional arterial infusion of protease inhibitor and antibiotics in the management of acute necrotizing pancreatitis. Pancreatology. 2001;1:668–73 (level 3b).CrossRefPubMed Takeda K, Yamauchi J, Shibuya K, et al. Benefit of continuous regional arterial infusion of protease inhibitor and antibiotics in the management of acute necrotizing pancreatitis. Pancreatology. 2001;1:668–73 (level 3b).CrossRefPubMed
26.
Zurück zum Zitat Consensus Revision Committee on Early Diagnosis and Treatment of Acute Pancreatitis. Revised guidelines for the early diagnosis and treatment of acute pancreatitis by the Consensus Revision Committee, third edition. Pancreas. 2011;26:651–83. Consensus Revision Committee on Early Diagnosis and Treatment of Acute Pancreatitis. Revised guidelines for the early diagnosis and treatment of acute pancreatitis by the Consensus Revision Committee, third edition. Pancreas. 2011;26:651–83.
27.
Zurück zum Zitat Mine T, Akashi R, Igarashi Y, et al. Ministry of Health, Labour and Welfare Grant-in-Aid for Scientific Research. Research on measures for intractable disease. Survey on Intractable Diseases. 2008 Technical report on survey of intractable pancreatic disease 2009; 77–78. Mine T, Akashi R, Igarashi Y, et al. Ministry of Health, Labour and Welfare Grant-in-Aid for Scientific Research. Research on measures for intractable disease. Survey on Intractable Diseases. 2008 Technical report on survey of intractable pancreatic disease 2009; 77–78.
28.
Zurück zum Zitat Seta T, Noguchi Y. Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis. Gastrointest Endosc. 2011;73(4):700–706.e1-2.CrossRefPubMed Seta T, Noguchi Y. Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis. Gastrointest Endosc. 2011;73(4):700–706.e1-2.CrossRefPubMed
29.
Zurück zum Zitat Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002;56:488–95.CrossRefPubMed Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc. 2002;56:488–95.CrossRefPubMed
30.
Zurück zum Zitat Andriulli A, Solmi L, Loperfido S, et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol. 2004;2:713–8.CrossRefPubMed Andriulli A, Solmi L, Loperfido S, et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol. 2004;2:713–8.CrossRefPubMed
31.
Zurück zum Zitat Benvenutti S, Zancanella L, Piazzi L, et al. Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: a randomized placebo controlled multicenter study. Dig Liv Dis. 2006;38:S15.CrossRef Benvenutti S, Zancanella L, Piazzi L, et al. Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: a randomized placebo controlled multicenter study. Dig Liv Dis. 2006;38:S15.CrossRef
32.
Zurück zum Zitat Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy—Italian Group. N Engl J Med. 1996;335:919–23.CrossRefPubMed Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy—Italian Group. N Engl J Med. 1996;335:919–23.CrossRefPubMed
33.
Zurück zum Zitat Manes G, Ardizzone S, Lombardi G, et al. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc. 2007;65:982–7.CrossRefPubMed Manes G, Ardizzone S, Lombardi G, et al. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc. 2007;65:982–7.CrossRefPubMed
34.
Zurück zum Zitat Xiong GS, Wu SM, Zhang XW, et al. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res. 2006;39:85–90.CrossRefPubMed Xiong GS, Wu SM, Zhang XW, et al. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res. 2006;39:85–90.CrossRefPubMed
35.
Zurück zum Zitat Zheng M, Chen Y, Yang X, et al. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2007;7:6–13.CrossRefPubMedPubMedCentral Zheng M, Chen Y, Yang X, et al. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2007;7:6–13.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 2007;65:624–32.CrossRefPubMed Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 2007;65:624–32.CrossRefPubMed
37.
Zurück zum Zitat Rudin D, Kiss A, Wetz RV, et al. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol. 2007;22:977–83.CrossRefPubMed Rudin D, Kiss A, Wetz RV, et al. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol. 2007;22:977–83.CrossRefPubMed
38.
Zurück zum Zitat Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005;3:376–83.CrossRefPubMed Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol. 2005;3:376–83.CrossRefPubMed
39.
Zurück zum Zitat Ueki T, Otani K, Kawamoto K, et al. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol. 2007;42:161–7.CrossRefPubMed Ueki T, Otani K, Kawamoto K, et al. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol. 2007;42:161–7.CrossRefPubMed
40.
Zurück zum Zitat Yoo JW, Ryu JK, Lee SH, et al. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas. 2008;37:366–70.CrossRefPubMed Yoo JW, Ryu JK, Lee SH, et al. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas. 2008;37:366–70.CrossRefPubMed
41.
Zurück zum Zitat Dai HF, Wang XW, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepat Pancreat Dis Int. 2009;8:11–6. Dai HF, Wang XW, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepat Pancreat Dis Int. 2009;8:11–6.
42.
Zurück zum Zitat Elmunzer B, Waljee A, Elta G, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57:1262.CrossRefPubMed Elmunzer B, Waljee A, Elta G, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57:1262.CrossRefPubMed
43.
Zurück zum Zitat Zheng M-H, Xia H, Chen Y-P. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis. Gut. 2008;57:1632.PubMed Zheng M-H, Xia H, Chen Y-P. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis. Gut. 2008;57:1632.PubMed
44.
Zurück zum Zitat Akshintala VS, Hutfless SM, Colantuoni E, et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38(11–12):1325–37.CrossRefPubMed Akshintala VS, Hutfless SM, Colantuoni E, et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38(11–12):1325–37.CrossRefPubMed
45.
Zurück zum Zitat Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol. 2012;47(8):912–7.CrossRefPubMed Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol. 2012;47(8):912–7.CrossRefPubMed
46.
Zurück zum Zitat Singh P, Das A, Isenberg G, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc. 2004;60(4):544–50.CrossRefPubMed Singh P, Das A, Isenberg G, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc. 2004;60(4):544–50.CrossRefPubMed
47.
Zurück zum Zitat Andriulli A, Forlano R, Napolitano G, et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion. 2007;75(2–3):156–63.CrossRefPubMed Andriulli A, Forlano R, Napolitano G, et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks. Digestion. 2007;75(2–3):156–63.CrossRefPubMed
48.
Zurück zum Zitat Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73(2):275–82.CrossRefPubMed Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73(2):275–82.CrossRefPubMed
49.
Zurück zum Zitat Sofuni A, Maguchi H, Itoi T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007;5:1339–46.CrossRefPubMed Sofuni A, Maguchi H, Itoi T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007;5:1339–46.CrossRefPubMed
50.
Zurück zum Zitat Chahal P, Tarnasky PR, Petersen BT, et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009;7(8):834–9.CrossRefPubMed Chahal P, Tarnasky PR, Petersen BT, et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009;7(8):834–9.CrossRefPubMed
51.
Zurück zum Zitat Fehmi SMA, Schoenfeld PS, Scheiman JM, et al. 5 Fr prophylactic pancreatic stents are easier to place and require fewer guide wires than 3 Fr stents. Gastrointest Endosc. 2008;67:AB328–9.CrossRef Fehmi SMA, Schoenfeld PS, Scheiman JM, et al. 5 Fr prophylactic pancreatic stents are easier to place and require fewer guide wires than 3 Fr stents. Gastrointest Endosc. 2008;67:AB328–9.CrossRef
52.
Zurück zum Zitat Smith MT, Sherman S, Ikenberry SO, et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc. 1996;44:268–75.CrossRefPubMed Smith MT, Sherman S, Ikenberry SO, et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc. 1996;44:268–75.CrossRefPubMed
53.
Zurück zum Zitat Bailey AA, Bourke MJ, Williams SJ, et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008;40:296–301.CrossRefPubMed Bailey AA, Bourke MJ, Williams SJ, et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008;40:296–301.CrossRefPubMed
54.
Zurück zum Zitat Katsinelos P, Paroutoglou G, Kountouras J, et al. A comparative study of standard ERCP catheter and hydrophilic guide wire in the selective cannulation of the common bile duct. Endoscopy. 2008;40:302–7.CrossRefPubMed Katsinelos P, Paroutoglou G, Kountouras J, et al. A comparative study of standard ERCP catheter and hydrophilic guide wire in the selective cannulation of the common bile duct. Endoscopy. 2008;40:302–7.CrossRefPubMed
55.
Zurück zum Zitat Kawakami H, Maguchi H, Mukai T, et al. A multicenter, prospective, randomized study of selective bile duct cannulation performed by multiple endoscopists: the BIDMEN study. Gastrointest Endosc. 2012;75:362–72.CrossRefPubMed Kawakami H, Maguchi H, Mukai T, et al. A multicenter, prospective, randomized study of selective bile duct cannulation performed by multiple endoscopists: the BIDMEN study. Gastrointest Endosc. 2012;75:362–72.CrossRefPubMed
56.
Zurück zum Zitat Kobayashi G, Fujita N, Imaizumi K, et al. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial. Dig Endosc. 2013;25:295–302.CrossRefPubMed Kobayashi G, Fujita N, Imaizumi K, et al. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial. Dig Endosc. 2013;25:295–302.CrossRefPubMed
57.
Zurück zum Zitat Cheung J, Tsoi KK, Quan W-L, et al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc. 2009;70:1211–9.CrossRefPubMed Cheung J, Tsoi KK, Quan W-L, et al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc. 2009;70:1211–9.CrossRefPubMed
58.
Zurück zum Zitat Tse F, Yuan Y, Moayyedi P, et al. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database Syst Rev. 2012;12:CD009662.PubMed Tse F, Yuan Y, Moayyedi P, et al. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database Syst Rev. 2012;12:CD009662.PubMed
Metadaten
Titel
Clinical practice guideline for post-ERCP pancreatitis
verfasst von
Tetsuya Mine
Toshio Morizane
Yoshiaki Kawaguchi
Ryukichi Akashi
Keiji Hanada
Tetsuhide Ito
Atsushi Kanno
Mitsuhiro Kida
Hiroyuki Miyagawa
Taketo Yamaguchi
Toshihiko Mayumi
Yoshifumi Takeyama
Tooru Shimosegawa
Publikationsdatum
26.06.2017
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 9/2017
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-017-1359-5

Weitere Artikel der Ausgabe 9/2017

Journal of Gastroenterology 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.